KDM5B-driven glucose metabolic reprogramming promotes enzalutamide resistance in prostate cancer via the lactate/ hnRNPA1 lactylation/AR-V7 axis
Favorite
Share
More Options
28

Open in WPS to view all 28 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
